What's in Archigen Biotech Limited's pipeline?

Archigen Biotech Limited has 1 drugs in our index: 0 marketed, 0 filed, 1 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Archigen Biotech Limited's portfolio?

Top competitors by shared drug class: AbbVie, AstraZeneca, BioLineRx, Ltd., Bright Minds Biosciences Pty Ltd, Celtic Pharma Development Services.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/archigen-biotech-limited.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-06-10 · How we verify

Archigen Biotech Limited — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Archigen Biotech Limited pipeline: 0 marketed, 0 filed, 1 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 1 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
SAIT101	SAIT101	phase 3	S1P1 receptor modulator	S1P1	Immunology

Therapeutic area mix

Immunology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

AbbVie · 1 shared drug class
AstraZeneca · 1 shared drug class
BioLineRx, Ltd. · 1 shared drug class
Bright Minds Biosciences Pty Ltd · 1 shared drug class
Celtic Pharma Development Services · 1 shared drug class
Daewoong Pharmaceutical Co. LTD. · 1 shared drug class
Eric Stephen Winer, MD · 1 shared drug class
Ferrer Internacional S.A. · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Archigen Biotech Limited:

Cite this brief

Drug Landscape (2026). Archigen Biotech Limited — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/archigen-biotech-limited. Accessed 2026-06-10.